MAPT and Alzheimer disease: To detect the ubiquitination and tau oligomers interaction in situ in AD brains, we performed a proximity ligation assay (PLA) using T22 antibody, which specifically recognizes tau oligomers and FK2 antibody, which recognizes ubiquitinated proteins.